By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 ...

Becomes the first and only FDA-cleared seizure detection algorithm for pre-term neonates through adults enabling rapid bedside detection, diagnosis, and treatment of non-convulsive seizures SUNNYVALE, ...

CeriBell supported its latest FDA clearance with EEG data from more than 700 patients. It says that represented the largest ...

Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies SUNNYVALE, Calif., ...

The FDA clearance was supported by EEG data from more than 700 patients, which the company describes as the largest known validation dataset ever used for a neonatal seizure detection system. CeriBell ...

A wrist-worn device that uses machine learning accurately detects different seizure types in findings that have the potential to revolutionize the management of patients with epilepsy. "We have set a ...

MINNEAPOLIS/ST. PAUL (08/27/2024) — Published in the Journal of Neural Engineering, a research team led by the University of Minnesota Medical School evaluated the reliability of human experts in ...

Researchers from the Indian Institute of Technology – Delhi have come up with a novel algorithm that can localise the epileptogenic zone using a patient's EEG data. In cases of drug-resistant ...

A wearable device that can alert patients and caregivers minutes before a seizure occurs is set to launch across Europe.

Based on Ceribell’s assessment, its Clarity algorithm now provides coverage across the largest age range ever addressed by a seizure detection technology. This offers hospitals, particularly emergency ...

SUNNYVALE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...